Brief: Gensight Biologics 9-Month Cash Position At Eur 19.9 Mln

Gensight Biologics SA

28/10/2022 17:30

Oct 28 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS REPORTS CASH POSITION AND REVENUES AS
OF
SEPTEMBER 30, 2022
    * EUR 13.9 MILLION OF CASH AS OF SEPTEMBER 30, 2022; RUNWAY
CONFIRMED TO EARLY Q1 2023
    * COMPANY IS FINALIZING A MINIMALLY DILUTIVE FINANCING AND
EXPECTS
TO COMMUNICATE IN COMING DAYS
    * AS OF SEPTEMBER 30, 2022, GENSIGHT BIOLOGICS' NUMBER OF
OUTSTANDING SHARES WAS 46,335,591 ORDINARY SHARES
    * 9 MONTHS  REVENUES FROM SALE OF LUMEVOQ® UNDER TEMPORARY
AUTHORIZATION FOR USE IN FRANCE EUR 3.1 MILLION

Source text for Eikon:  ID:nBw9lr0pfa 
Further company coverage:  SIGHT.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))